Literature DB >> 30312932

Anti-inflammatory abietanes diterpenoids isolated from Tripterygium hypoglaucum.

Xing-Long Chen1, Fang Liu1, Xue-Rong Xiao1, Xiu-Wei Yang2, Fei Li3.   

Abstract

Tripterygium hypoglaucum (H. Lév.) Hutch. has been used to remedy rheumatoid arthritis, however, it shows frequent toxicity to the body. In this study, liquid chromatograph-mass spectrometer (LC-MS) was guided to characterize abietanes diterpenoids with anti-inflammatory activity from the stem of T. hypoglaucum. Thirteen undescribed abietanes diterpenoids were isolated and purified, and their chemical structure was identified using various spectroscopic methods. These compounds belonged to abietanes with splitting C ring, abietanes with benzenoid rings, diterpene quinoids, diterpene quinoids with lactone rings, and abietanes with benzenoid and lactone rings, respectively. Lipopolysaccharide (LPS)-induced nitric oxide (NO) production in RAW264.7 macrophages was used to evaluate anti-inflammatory activity of the compounds. The results indicated that hypoglicin B-G and hypoglicin J-M exhibited inhibitory activity of NO production with the IC50 values of 6.01, 25.21, 8.29, 3.63, 0.72, 0.89, 36.91, 0.82, 2.85, 11.92 μM, respectively. Among these compounds, compound hypoglicin L showed high anti-inflammatory activity and low toxicity (SI = 5.02 × 104). Further QPCR analysis revealed that hypoglicin D and hypoglicin L can inhibit the mRNA expression of iNOS in LPS-stimulated RAW264.7 cells at doses of 12.5 and 3.13 μM, respectively. Taken together, ten anti-inflammatory diterpenoids were found from T. hypoglaucum in this study.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Anti-inflammatory activity; Diterpenoids; LC-MS; Tripterygium hypoglaucum (H. Lév.) Hutch. (Celastraceae)

Mesh:

Substances:

Year:  2018        PMID: 30312932     DOI: 10.1016/j.phytochem.2018.10.001

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  4 in total

1.  A cytochrome P450 CYP81AM1 from Tripterygium wilfordii catalyses the C-15 hydroxylation of dehydroabietic acid.

Authors:  Jiadian Wang; Ping Su; Linhui Gao; Yifeng Zhang; Jian Wang; Lichan Tu; Yujun Zhao; Yun Lu; Yan Yin; Luqi Huang; Wei Gao
Journal:  Planta       Date:  2021-10-13       Impact factor: 4.116

2.  Network pharmacology modeling identifies synergistic interaction of therapeutic and toxicological mechanisms for Tripterygium hypoglaucum Hutch.

Authors:  Dan Zhang; Yizhu Dong; Jintao Lv; Bing Zhang; Xiaomeng Zhang; Zhijian Lin
Journal:  BMC Complement Med Ther       Date:  2021-01-15

3.  Modified ent-Abietane Diterpenoids from the Leaves of Suregada zanzibariensis.

Authors:  Thobias M Kalenga; Jackson T Mollel; Joanna Said; Andreas Orthaber; Jas S Ward; Yoseph Atilaw; Daniel Umereweneza; Monica M Ndoile; Joan J E Munissi; Kari Rissanen; Edward Trybala; Tomas Bergström; Stephen S Nyandoro; Mate Erdelyi
Journal:  J Nat Prod       Date:  2022-09-08       Impact factor: 4.803

4.  Evaluating the therapeutic efficacy of the Chinese herbal medicine Yishen Tongbi decoction in patients with active rheumatoid arthritis: protocol for a randomized, controlled, noninferiority trial.

Authors:  Lianyu Zhao; Meilin Li; Yanping Xu; Lijuan Liu; Mingying Zhang; Guangxing Chen
Journal:  Trials       Date:  2019-12-30       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.